Epidemiological Profile of Herpes Zoster and Its Association with Comorbidities in Al-Nasiriyah, Iraq
DOI:
https://doi.org/10.46966/msjar.v6i4.328Keywords:
Herpes Zoster; Varicella Zoster Virus; Epidemiology; ComorbidityAbstract
Background: Herpes zoster (HZ), resulting from the reactivation of the varicella-zoster virus (VZV), is a significant cause of morbidity. Understanding its local epidemiology and association with comorbidities is crucial for public health planning. Objective: This study aimed to investigate the demographic characteristics and prevalence of comorbid conditions among patients with HZ in Al-Nasiriyah, Iraq. Materials and Methods: A retrospective, cross-sectional study was carried out through the medical records of 132 HZ patients at al-Hussain Teaching Hospital. Demographic patient characteristics, clinical presentation, history of varicella and comorbidities (eg diabetes mellitus and hypertension) were evaluated. Results: A total of 132 (86 males, 65.2% and 46 females, 34.8%) definite intellectual disability (ID) patients were included in the study. The greatest disease prevalence (34.1%) pertained to patients older than 50 years old. Most of them (71.2%) mentioned previous varicella infection. Comorbidities were frequent and hypertension was found in 15.1% of cases, followed by diabetes mellitus in 10.6%. Those comorbidities were mostly detected for people over 50 years of age (respectively, 60.0% and 57.1% in hypertension and diabetes cases within the HZ cohort). Conclusion: Herpes zoster occurs primarily in the elderly of this Iraqi population and is strongly correlated with systemic diseases including hypertension and diabetes mellitus. These data demonstrate the utility of HZ as a potential marker for underlying chronic diseases and provide rationale for increased surveillance and vaccine approaches to high-risk children.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Alyaa Mousa Ali, Intidhaar Naeem Abid, Sabah Hasan Rhadi

This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.


















